Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

527 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of biomarkers predictive of metastasis development in early-stage colorectal cancer using network-based regularization.
Peixoto C, Lopes MB, Martins M, Casimiro S, Sobral D, Grosso AR, Abreu C, Macedo D, Costa AL, Pais H, Alvim C, Mansinho A, Filipe P, Costa PMD, Fernandes A, Borralho P, Ferreira C, Malaquias J, Quintela A, Kaplan S, Golkaram M, Salmans M, Khan N, Vijayaraghavan R, Zhang S, Pawlowski T, Godsey J, So A, Liu L, Costa L, Vinga S. Peixoto C, et al. Among authors: abreu c. BMC Bioinformatics. 2023 Jan 16;24(1):17. doi: 10.1186/s12859-022-05104-z. BMC Bioinformatics. 2023. PMID: 36647008 Free PMC article.
Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases.
Ferreira AR, Bettencourt M, Alho I, Costa AL, Sousa AR, Mansinho A, Abreu C, Pulido C, Macedo D, Vendrell I, Pacheco TR, Costa L, Casimiro S. Ferreira AR, et al. Among authors: abreu c. J Bone Oncol. 2017 Jan 28;6:16-21. doi: 10.1016/j.jbo.2017.01.002. eCollection 2017 Mar. J Bone Oncol. 2017. PMID: 28194325 Free PMC article.
HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcome.
Golkaram M, Salmans ML, Kaplan S, Vijayaraghavan R, Martins M, Khan N, Garbutt C, Wise A, Yao J, Casimiro S, Abreu C, Macedo D, Costa AL, Alvim C, Mansinho A, Filipe P, Marques da Costa P, Fernandes A, Borralho P, Ferreira C, Aldeia F, Malaquias J, Godsey J, So A, Pawlowski T, Costa L, Zhang S, Liu L. Golkaram M, et al. Among authors: abreu c. NPJ Genom Med. 2021 Feb 15;6(1):13. doi: 10.1038/s41525-021-00177-w. NPJ Genom Med. 2021. PMID: 33589643 Free PMC article.
Predictive and Therapeutic Implications of a Novel PLCγ1/SHP2-Driven Mechanism of Cetuximab Resistance in Metastatic Colorectal Cancer.
Cruz-Duarte R, Rebelo de Almeida C, Negrão M, Fernandes A, Borralho P, Sobral D, Gallego-Paez LM, Machado D, Gramaça J, Vílchez J, Xavier AT, Ferreira MG, Miranda AR, Mansinho H, Brito MJ, Pacheco TR, Abreu C, Lucia-Costa A, Mansinho A, Fior R, Costa L, Martins M. Cruz-Duarte R, et al. Among authors: abreu c. Clin Cancer Res. 2022 Mar 15;28(6):1203-1216. doi: 10.1158/1078-0432.CCR-21-1992. Clin Cancer Res. 2022. PMID: 34980600 Free PMC article.
Bone Health in Metastatic Cancer.
Ventura C, Núñez SV, Gonçalves A, Abreu C, Costa L. Ventura C, et al. Among authors: abreu c. Semin Oncol Nurs. 2022 Apr;38(2):151278. doi: 10.1016/j.soncn.2022.151278. Epub 2022 Apr 15. Semin Oncol Nurs. 2022. PMID: 35431084 Review.
Oncobiology and treatment of breast cancer in young women.
Kumar R, Abreu C, Toi M, Saini S, Casimiro S, Arora A, Paul AM, Velaga R, Rameshwar P, Lipton A, Gupta S, Costa L. Kumar R, et al. Among authors: abreu c. Cancer Metastasis Rev. 2022 Sep;41(3):749-770. doi: 10.1007/s10555-022-10034-6. Epub 2022 Apr 30. Cancer Metastasis Rev. 2022. PMID: 35488982 Review.
527 results